A simple blood test could spare elderly breast cancer patients from unnecessary surgery
For women 70 and older with estrogen receptor-positive breast cancer, a blood test measuring circulating tumor DNA fragments may reveal early whether hormone-blocking therapy alone is working — potentially sparing some patients from surgery, radiation, and their side effects.








